{"organizations": [], "uuid": "0c670a50bc1b21db967025a9d44d7b622ec9435b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180204.html", "section_title": "Archive News &amp; Video for Sunday, 04 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/frutarom-inds-ma-ibr/frutarom-buys-israeli-biotech-research-for-21-mln-idUSL8N1PU064", "country": "US", "domain_rank": 408, "title": "Frutarom buys Israeli Biotech Research for $21 mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-02-04T16:16:00.000+02:00", "replies_count": 0, "uuid": "0c670a50bc1b21db967025a9d44d7b622ec9435b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/frutarom-inds-ma-ibr/frutarom-buys-israeli-biotech-research-for-21-mln-idUSL8N1PU064", "ord_in_thread": 0, "title": "Frutarom buys Israeli Biotech Research for $21 mln", "locations": [], "entities": {"persons": [{"name": "tova cohen", "sentiment": "none"}, {"name": "steven scheer", "sentiment": "none"}, {"name": "ori yehudai", "sentiment": "none"}], "locations": [{"name": "frutarom", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "frutarom industries ltd", "sentiment": "negative"}, {"name": "israeli biotech research", "sentiment": "negative"}, {"name": "ibr", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "JERUSALEM, Feb 4 (Reuters) -\n* Israeli flavours and ingredients maker Frutarom Industries Ltd said on Sunday it bought 100 percent of Israeli Biotech Research (IBR) for $21 million in a deal financed through bank debt.\n* It was the first acquisition of the year for Frutarom after buying 12 companies in 2017. It has made 32 acquisitions since 2015.\n* IBR develops, manufactures and markets natural active ingredients for the cosmetics and dietary supplements industries. It had sales of $7.4 million in 2017.\n* “The IBR acquisition is ... an important step in implementing Frutarom’s strategic plan to develop a worldwide business in the growing and profitable fields of natural cosmetics,” said Frutarom CEO Ori Yehudai. (Reporting by Steven Scheer; Editing by Tova Cohen)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-04T16:16:00.000+02:00", "crawled": "2018-02-05T15:20:23.024+02:00", "highlightTitle": ""}